Skip to main content

Table 2 Interventions after PET/CT evaluation

From: FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma

Interventions

No. of patients

(%)

Single intervention

44

 

(44)

  Sunitinib

 

19

 

  Sorafenib

 

20

 

  IFN-α

 

4

 

  Temsirolimus

 

1

 

2 interventions

22

 

(22)

  TKI to mTORI

 

10

 

  TKI to TKI

 

9

 

  mTORI to TKI

 

3

 

3 interventions

20

 

(20)

3 < interventions

15

 

(15)

TKI

96

 

(95)

mTORI

39

 

(39)

IFN-α

16

 

(16)

Metastasectomy

6

 

(6)

Nephrectomy

5

 

(5)

  1. Abbrebiations: IFN-α interferon-α, TKI tyrosine kinase inhibitor, mTORI mTOR inhibitor